The European cleansing solutions market was valued at $23 million in 2013 and is expected to reach $24 million by 2018, at a CAGR of 1.5% during the forecast period, 2013 to 2018.
The report analyzes the market for cleansing solutions in terms of 5 segments, such as normal saline solutions, povidone solutions, hydrogen peroxide cleansers, sodium hypochlorite (Dakin solutions), and commercial cleansers. All these segments experienced a positive growth till 2013, as physicians mainly choose to clean wounds with cleansers, which account for over 50% of the chronic and severe wound care market. The cleansing solutions markets have been witnessing significant growth because there are many wounds that do not require anything but protection from infection. Hence, traditional products will definitely remain the first choice for physicians across. Research has established that the use of antiseptic cleansing solutions may compromise the healing process and, as a result, the use of normal saline as a cleansing solution is widely recommended.
The cleansing solutions market in Europe is at the maturity phase due to the lack of product innovations in this category and the use of advanced and active wound care therapy, which is showing faster wound healing in lesser time. In Europe, chronic conditions such as diabetic foot ulcers, venous ulcers, and pressure ulcers are on the rise. Severe foot ulcers lead to amputation and hence, need the utmost care. The factors driving the market in Europe include the growing aging population, increase in chronic wounds, and increase in surgeries.
The report also provides an extensive competitive landscaping of the leading companies operating in this market. The main companies extensively covered in this report are Smith & Nephew, 3M healthcare, Johnson and Johnson, Derma Sciences, Covidien, and Molnlycke Healthcare. Furthermore, the segment and country-specific company shares, news & deals, M&A, segment-specific pipeline products, product approvals, and product recalls of the major companies operating in cleansing solutions market have been detailed in this report.
Along with the market data, customize the MMM assessments to meet your company’s specific needs. Customize to get a comprehensive summary of the industry standards and deep dive analysis of the following parameters:
- Usage pattern (in-depth trend analysis) of products (segment-wise)
- Product matrix, which gives a detailed comparison of product portfolio of each company mapped at country and sub-segment levels
- End-user adoption rate analysis of the products (segment-wise and country-wise)
- A comprehensive coverage of product approvals, pipeline products, and product recalls
- Country-specific prevalence of ulcers, burns, and surgical wounds
- Country-specific number of surgeries
- Country-specific patient pool of skin ulcers, diabetic ulcers, and neuropathic ulcers
- Disease progression (pattern analysis)
Surgeons’/Physicians’ perception analysis
- Fast turn-around analysis of surgeons’ responses to cleansing solutions market events and trends
- Pattern analysis of usage of products by physicians
- Surgeons’ opinions about products from different companies
- Surgeons’ qualitative inputs on epidemiology data
Brand/Product Perception Matrix
- A comprehensive study of customers’ perception and behavior through our inbuilt social connect tool checking the virality and tonality of blogs
- An analysis of overall brand usage and familiarity and brand advocacy distribution (Detractor/Neutral/Familiar)
Alternative Products: Impact analysis
MMM’s Healthcare Decision Making Quadrant It is an innovative and useful quadrant for vendors who wish to analyze the potential growth markets based on parameters such as patient dynamics (patient pool, epidemiology of disease, preference towards surgeries/alternative therapies) and macroeconomic indicators (aging population, reimbursement scenario, treatment rate and healthcare expenditure)
1.1 Objective of the study
1.2 Market Definitions
1.3 Market Segmentation & Aspects Covered
1.4 Research Methodology
1.4.1 Assumptions (Market Size, Forecast, etc)
2 Executive Summary
3 Market Overview
4 Cleansing solutions-Europe, By Geographies
4.1 Cleansing solutions-United Kingdom
4.2 Cleansing solutions-France
4.3 Cleansing solutions-Germany
4.4 Cleansing solutions-Italy
4.5 Cleansing solutions-Spain
4.6 Cleansing solutions-Europe - Other Geographies
Please fill in the form below to receive a free copy of the Summary of this Report
Please visit http://www.micromarketmonitor.com/custom-research-services.html to specify your custom Research Requirement
Asian Basic Wound Care Market
The Asian Basic Wound Care Market was valued at $71 million in 2013 and is expected to reach $83 million by 2018, at a CAGR of 3.2%. The report “Asian Basic Wound Care Market forecast, 2012-2018" analyzes the market of Basic Wound Care by 3 segments such as Tapes, Dry dressings and Cleansing solutions. The main companies operating in this market and extensively covered in this report are Derma Sciences, Smith & Nephew, 3M healthcare, Johnson and Johnson, Covidien, Molnlycke healthcare and others.
European Basic Wound Care Market
The European Basic Wound Care Market was valued at $114 million in 2013 and is expected to reach $121 million by 2018, at a CAGR of 1.4%. The report “European Basic Wound Care Market forecast, 2012-2018" analyzes the market of Basic Wound Care by 3 segments such as Tapes, Dry dressings and Cleansing solutions. The main companies operating in this and extensively covered in this report are Johnson and Johnson, Derma Sciences, Covidien and Molnlycke healthcare, Smith & Nephew, 3M healthcare and others.
North American Basic Wound Care Market
The North American Basic Wound Care Market was valued at $346 million in 2013 and is expected to reach $376 million by 2018, at a CAGR of 2%. The report “North American Basic Wound Care Market forecast, 2012-2018" analyzes the market of Basic Wound Care by 3 segments such as Tapes, Dry dressings and Cleansing solutions. The main companies operating in basic wound care market and extensively covered in this report are Smith & Nephew, 3M healthcare, Johnson and Johnson, Derma Sciences, Covidien, Molnlycke healthcare and others.